Related by context. All words. (Click for frequent words.) 71 non nucleoside inhibitor 71 oral prodrug 70 dasatinib Sprycel ® 70 Melphalan 69 erlotinib Tarceva ® 69 Cloretazine ® 69 docetaxel Taxotere R 68 vapreotide acetate 68 MAGE A3 ASCI 68 nucleoside analog 68 Aflibercept 68 GW# [003] 68 intranasal formulation 68 Zorbtive TM 67 IMiDs ® 67 Personalized Immunotherapy 67 Xeloda ® 67 Traficet EN 67 Degarelix 67 IAP inhibitor 67 targeted radiotherapeutic 67 Bosutinib 67 Panzem R 67 Mg Usa 67 alfa 2a 67 docetaxel Taxotere ® 67 liposomal formulation 67 mertansine 67 sunitinib Sutent ® 67 evaluating tivozanib 66 Pradefovir 66 Irinotecan 66 Pafuramidine 66 Amplimexon 66 lexidronam injection 66 methylnaltrexone bromide 66 AAG geldanamycin analog 66 Kamada AAT 66 Pegloticase 66 trastuzumab Herceptin R 66 receptor tyrosine kinase inhibitor 66 Indomethacin 66 brand ciclesonide HFA 66 PrevOnco 66 SPRYCEL ® 66 vinca alkaloid 66 thalidomide Thalomid 66 potent triglyceride lowering 66 virus HCV protease inhibitor 66 bortezomib Velcade R 66 sorafenib tablets 66 beta 1a 66 Silodosin 66 Iluvien ® 66 Tarceva TM 66 Inhalation Aerosol 66 ALVESCO ® 66 topical gel formulation 66 histamine dihydrochloride 66 TRO# 66 XL# anticancer compounds 66 Xcellerated T Cells 66 Phase #b/#a clinical 66 vinorelbine tartrate 66 Bendamustine 66 dasatinib Sprycel 65 Ovidrel 65 Vidaza azacitidine 65 acyclovir Lauriad R 65 Panzem R NCD 65 Genasense ® oblimersen 65 echinocandin 65 lapatinib Tykerb 65 Phase IIb Trial 65 multi kinase inhibitor 65 selective A2A adenosine receptor 65 Archexin 65 cromolyn sodium 65 hormone LHRH antagonist 65 Initiates Enrollment 65 PEGylated Fab fragment 65 PANVAC VF 65 Talabostat 65 FOLOTYN ® 65 VNP#M 65 Interferon beta 1a 65 orally inhaled 65 Aztreonam lysine 65 Angiocept 65 plus prednisone prednisolone 65 Meets Primary Endpoint 65 R Saizen R 65 pentostatin 65 capecitabine Xeloda 65 overactive bladder AA# 65 alpha 2b 65 Entecavir 65 KNS # 65 reslizumab 65 Teysuno 65 Dose Ranging Study 65 Phase #b/#a trial 65 Clevudine 65 TNF Tumor Necrosis Factor 65 CYT# QbG# 65 highly selective inhibitor 65 tenofovir disoproxil fumarate Viread 65 Belimumab 65 DEB# 65 Piperacillin 65 topically applied SEPA 65 YONDELIS 65 PDE4 inhibitor 65 RhuDex ® 65 phase IIb clinical 65 delivers fluocinolone acetonide FA 65 miconazole Lauriad ® 65 tenofovir Viread 65 Nitazoxanide 65 small molecule Hedgehog 65 volociximab 65 2 methoxyestradiol 65 MEK inhibitor 65 Fludara ® 65 bevacizumab Avastin ® 65 refractory chronic lymphocytic 65 etanercept Enbrel 65 ALVESCO R 65 LymphoStat B belimumab 65 Tezampanel 65 nilotinib Tasigna ® 65 Serostim ® 65 Crofelemer budesonide foam 65 tazobactam 65 adefovir dipivoxil 65 imatinib Gleevec ® 65 ® lenalidomide 65 CCR5 antagonist 65 docetaxel Taxotere 65 arsenic trioxide injection 65 nucleotide analogue 65 intravesical infusion therapy 64 Annamycin 64 Proxinium TM 64 Ganciclovir 64 octreotide acetate 64 lenalidomide Revlimid R 64 Methylnaltrexone 64 HGS# 64 pertuzumab 64 TLK# 64 Vidaza R 64 systemic RNAi therapeutic 64 Naive Patients 64 Sapacitabine 64 PNT# 64 temsirolimus Torisel ® 64 Pruvel TM 64 EOquin TM 64 Phase III Clinical Trial 64 alvespimycin 64 Phase Ib clinical 64 Tocilizumab 64 bortezomib Velcade 64 alefacept 64 Mg Uk 64 COPEGUS R 64 Phase 1b clinical trials 64 iobenguane 64 IL# PE#QQR 64 PEGASYS ® 64 TELINTRA 64 herpetic keratitis 64 non porcine pancreatic 64 PF # [002] 64 Pivotal Phase III 64 alpha 2a 64 ThermoDox R 64 IMiD 64 irinotecan doxorubicin oxaliplatin paclitaxel 64 FOLFOX6 chemotherapy regimen 64 gemcitabine Gemzar ® 64 PNP inhibitor 64 chimeric monoclonal antibody 64 personalized cellular immunotherapy 64 Maribavir 64 sorafenib Nexavar 64 itraconazole Sporanox 64 Vandetanib 64 metastatic hormone refractory 64 IIa trial 64 ZOLINZA 64 topical ophthalmic 64 Nanobody 64 Pharmacokinetics PK 64 ribavirin RBV 64 SPL# Gel vaginal microbicide 64 Onalta ™ 64 investigational protease inhibitor 64 Combination REOLYSIN R 64 HGS ETR1 mapatumumab 64 Anidulafungin 64 Certolizumab pegol 64 5 HT3 antagonist 64 plasma kallikrein inhibitor 64 PRT# 64 Pegasys ® 64 Noxafil 64 SUTENT ® 64 humanised monoclonal antibody 64 Receives Orphan Drug Designation 64 diclofenac sodium 64 orally administered inhibitor 64 Omacetaxine 64 SinuNase ™ 64 GATTEX ™ 64 PEGylated interferon 64 oral antiviral 64 Myelodysplastic Syndrome MDS 64 Camptosar ® 64 trastuzumab Herceptin 64 phase III isavuconazole 64 Sustiva efavirenz 64 HCV NS5B polymerase 64 aflibercept VEGF Trap 64 Cannabinor 64 HCl capsules 64 Levoleucovorin 64 pralatrexate injection folate analogue 64 metastatic malignant 64 ficlatuzumab 64 TLR9 agonist 64 Deforolimus 64 HQK 64 Ziprasidone 64 Copegus ® 64 histone deacetylase HDAC inhibitor 64 boosted protease inhibitor 64 PI3K/Akt pathway inhibitor 64 Phase Ib IIa 64 humanized therapeutic 64 CCX# 64 TBC# 64 Pemetrexed 64 Granted Orphan Drug 64 BrachySil 64 CB2 selective receptor agonist 64 LymphoStat B TM 64 PSMA ADC 64 CA9 SCAN 64 lumiliximab 64 BLP# Liposome Vaccine 64 Aplidin 64 rhIGF-I/rhIGFBP-3 64 ASM8 64 galiximab 64 aldehyde dehydrogenase ALDH2 deficiency 64 Besivance 64 Capesaris 64 Teriflunomide 64 MyVax R 64 oral ridaforolimus 63 Gemzar ® 63 Dalbavancin 63 PEGylated anti 63 targeted antifolate 63 Fodosine 63 tiapamil 63 Alinia 63 Dabigatran etexilate 63 luteinizing hormone releasing 63 kidney urologic 63 SYN# 63 PrevOnco ™ 63 FUSILEV enhances 63 ADP receptor antagonist 63 novel prodrug 63 5 FU leucovorin 63 DAVANAT 63 dextromethorphan quinidine 63 elotuzumab 63 IV Busulfex 63 Iloperidone 63 R sorafenib tablets 63 Aztreonam 63 oral dihydropyrimidine dehydrogenase DPD 63 MT#/MEDI-# 63 EDEMA3 63 Hsp# Inhibitor 63 oral dual endothelin 63 unique alkylating agent 63 RhuDex 63 Initiates Phase II 63 phase IIa clinical 63 Eraxis 63 5 fluorouracil leucovorin 63 Atripla combines 63 Initiate Phase 63 Phase 2b Clinical Trial 63 Investigational Oral 63 dihydrochloride 63 mTOR inhibitor 63 Toremifene 63 Announces Tentative Approval 63 ara C 63 topical ocular 63 defensin mimetic antibiotic 63 BENICAR HCT 63 polymerase inhibitor 63 IMiDs R 63 oral nucleoside analogue 63 JAK inhibitor 63 Kahalalide F 63 oropharyngeal candidiasis OPC 63 HDAC Inhibitor 63 Parkinson disease levodopa induced 63 Pertuzumab 63 generation purine nucleoside 63 Telintra 63 nucleoside reverse transcriptase inhibitor 63 cetuximab Erbitux R 63 hypoxia selective 63 lucinactant 63 Aurexis 63 LHRH antagonist 63 Luveniq 63 Elagolix 63 CYT# potent vascular disrupting 63 relapsed MM 63 CCR5 mAb 63 rilonacept 63 Cerebril TM 63 Duromist ™ 63 CEQ# 63 Fluticasone 63 CIMZIA TM 63 INCB# [001] 63 Zenvia ™ 63 Nutra Pharma wholly owned 63 adenosine A2A 63 accumulate preferentially 63 Safinamide 63 Ecallantide 63 cetrorelix pamoate 63 novel VDA molecule 63 fosbretabulin 63 oral proteasome inhibitor 63 paclitaxel Taxol R 63 Peginterferon alfa 2b 63 signal transduction inhibitor 63 pharmacokinetic PK study 63 Boceprevir 63 Fulvestrant 63 PKC# 63 OMP #R# 63 Muraglitazar 63 IMA# 63 Epivir 63 novel topoisomerase 63 fluoroquinolone class 63 Phase IIIb clinical 63 IMiDs ® compound 63 oral rivaroxaban 63 Phase Ib clinical trials 63 GLP toxicology studies 63 PDX pralatrexate 63 Daclizumab 63 Elotuzumab 63 RhuDex R 63 Augment TM 63 Vitrasert R 63 radiation sensitizer 63 Troxatyl 63 Myocet 63 Obatoclax 63 Zolinza 63 trastuzumab DM1 T DM1 63 erlotinib Tarceva R 63 ciprofloxacin hydrochloride 63 CBLC# 63 ISENTRESS raltegravir 63 Cardio Vascu Grow 63 Bezielle 63 formoterol fumarate 63 capsules USP 63 long acting muscarinic 63 Darunavir 63 refractory gout 63 BAL# [002] 63 Aptivus ® 63 oncolytic virus therapies 63 albiglutide 63 #mg ATC 63 ELADUR ™ 63 Nexavar ® 63 Cellegesic 63 ritonavir boosted 63 PSN# [002] 63 Fx #A 63 peripherally acting 63 Genasense ® 63 PegIFN 63 Exemestane 63 NDA Submission 63 First Patient Dosed 63 Gemzar gemcitabine 63 triggers apoptosis programmed 63 SIR Spheres 63 OMNARIS HFA 63 Androxal TM 63 Phase IIa trials 63 Moxifloxacin 63 HYVISC ® treatment 63 vidofludimus 63 HuMax EGFr 62 assessing T DM1 62 selective androgen receptor modulator 62 GVAX ® 62 HuMax CD4 62 pegylated alpha interferon 62 Onconase 62 Vidaza ® 62 Mipomersen 62 Belerofon 62 Phase 1b trial 62 memantine HCl 62 anticancer compound 62 abacavir lamivudine 62 Ophena TM 62 Albuferon TM 62 QLT# 62 molecular imaging radiopharmaceutical 62 VEGFR2 inhibitor 62 AKT inhibitor 62 Cloretazine 62 lenalidomide Revlimid 62 TO AVOID PREGNANCY WHILE 62 investigational humanized monoclonal antibody 62 Gentamicin Surgical Implant 62 Edurant 62 Tanespimycin 62 hypoxia activated prodrug 62 visilizumab 62 pan histone deacetylase 62 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 62 Factor VIIa 62 dyskinesia PD LID 62 pegylated interferon alpha 62 DURIN TM 62 Copegus R 62 Olaparib 62 Seliciclib 62 RH1 62 Prochymal TM 62 Clolar ® 62 Tesetaxel 62 thymalfasin 62 midstage clinical 62 IMPDH inhibitor 62 AEG# 62 Phase IIb III 62 KRN# 62 Liposomal 62 UPLYSO 62 BRAF inhibitor 62 PhotoPoint R 62 Advagraf 62 Mitoxantrone 62 recurrent metastatic ovarian cancer 62 demonstrated antitumor activity 62 Phase 2b Study 62 Parathyroid Hormone 62 pregabalin Lyrica 62 paclitaxel Taxol ® 62 Abiraterone acetate 62 Fast Track Status 62 mapatumumab 62 Truvada emtricitabine 62 MKC# MKC# PP 62 imexon 62 Completes Patient Enrollment 62 novel oral anticoagulant 62 Raptiva ® 62 topical antifungal 62 Medidur ™ FA 62 Initiates Clinical 62 hormone agonist 62 pegylated interferon alfa 2a 62 pomalidomide 62 GSK# [001] 62 TRANSDUR Bupivacaine 62 IAP inhibitors 62 Randomized Double blind 62 chemotherapy cisplatin 62 VALSTAR 62 Aplidin R 62 baminercept 62 Adjuvant Treatment 62 oral picoplatin 62 FDA APPROVES 62 Rigel R# 62 rNAPc2 62 Vertex hepatitis C 62 Submits NDA 62 Panzem NCD 62 Kuvan sapropterin dihydrochloride 62 somatostatin analog 62 Peginterferon 62 GLPG# 62 systemic anaplastic large 62 VELCADE melphalan 62 Temsirolimus 62 DB# [003] 62 EPIVIR 62 pseudobulbar affect PBA 62 phase IIb trial 62 HuMax TAC 62 dexamethasone Decadron 62 Prothrombin 62 VISICOL R 62 Orally administered 62 regorafenib 62 Civacir 62 INSPIRE Trial Phase III 62 oral chemotherapeutic agent 62 Dacogen decitabine 62 StemEx 62 Empatic ™ 62 treat benign prostatic 62 SinuNase TM 62 Phase Ib study 62 DermaVir Patch 62 oxazolidinone 62 Initiate Clinical Trial 62 non resectable metastatic 62 Argatroban 62 Xcytrin R 62 SomatoKine 62 Pegylated interferon 62 ZACTIMA 62 IDI MRSA 62 PEG interferon 62 administered subcutaneously 62 acetonide FA 62 immunotherapeutic agent 62 treat chronic sinusitis 62 II Clinical Trial 62 Zarnestra 62 topically administered 62 TAFA# 62 Darinaparsin 62 metaglidasen 62 Afinitor everolimus 62 metastatic castration resistant 62 ACAPODENE TM 62 SOLTAMOX TM tamoxifen citrate 62 Aurograb 62 GTC recombinant form 62 Proteo 62 blinded randomized placebo controlled 62 zonisamide SR 62 Lenocta TM 62 neratinib 62 treat male hypogonadism 62 RhuDex TM 62 combines bupropion 62 cisplatin gemcitabine 62 DFMO 62 non nucleoside HCV 62 NPC 1C 62 Azathioprine 62 mycophenolate mofetil 62 Simulect 62 Immune Globulin Human 62 trastuzumab Herceptin ® 62 myelodysplastic myeloproliferative diseases 62 registrational Phase 62 tramiprosate Alzhemed TM 62 Dacogen injection 62 HCV protease inhibitor 62 adalimumab Humira 62 TRIOLEX HE# APOPTONE HE# 62 delivery polymer matrix 62 SYCREST 62 catheter occlusion 62 Enzastaurin 62 Cancidas 62 TELCYTA 62 octreotide implant 62 Phase III Pivotal 62 generation Hsp# inhibitor 62 gets USFDA nod 62 bevacizumab Avastin R 62 proteasome inhibitor 62 HSP# inhibitor 62 tazarotene 62 subcutaneous formulation 62 Peg IFN 62 miconazole Lauriad R 62 Excellarate TM 62 intravesical instillation 62 FUSILEV ® 62 Pruvel ™ 62 inhaled formulation 62 Phase Ib II 62 tyrosine kinase inhibitor 62 CDK inhibitor 62 Nexavar sorafenib tablets 62 RSD# 62 ZEVALIN ® 62 TELINTRA R 62 Receives Approvable Letter 62 combretastatin A4 phosphate CA4P 62 NeuroSTAT ® 62 peginterferon alpha 2a 62 Initiates Phase III 62 Budesonide 61 Fondaparinux 61 Anturol TM 61 Wafer polifeprosan 61 Biliary System 61 rALLy clinical trial 61 Ceflatonin R 61 Pathway Inhibitor 61 pan HDAC inhibitor 61 IGF 1R inhibitor 61 Romidepsin 61 Launches Generic Version 61 Proellex TM 61 ketolide antibiotic 61 SAR# [002] 61 nucleotide analog 61 evaluating satraplatin 61 immunotherapeutic vaccine 61 cutaneous T 61 EGFR TKI 61 Files IND 61 Pazopanib 61 Intravitreal 61 MYCAMINE 61 AQ4N 61 Aliskiren 61 Qutenza TM 61 ATL# [002] 61 pharmacologically active isomer 61 liposomal doxorubicin 61 LEUKINE 61 Telik logo TELINTRA 61 Complicated Skin 61 Bortezomib 61 Kinase Inhibitor 61 molecular chaperone regulator 61 Leukine ® 61 forodesine 61 nasal calcitonin product 61 Xanafide 61 Through Glycoscience 61 CYP#A# CYP#D# 61 NEBIDO VANTAS SUPPRELIN LA 61 TYGACIL 61 R#/MEM # 61 Aurora Kinase 61 Anthim 61 DOXIL R 61 Posaconazole 61 tinidazole 61 mitogen activated ERK kinase 61 Copegus ribavirin 61 Panzem 61 Triapine R 61 Cotara ® 61 rHuPH# recombinant human 61 MOVIPREP R 61 thiazolides 61 basiliximab 61 Tofacitinib 61 Aeolus Pharmaceuticals Announces 61 Fingolimod 61 Quinamed 61 Tykerb lapatinib 61 Alocrest 61 hypereosinophilic syndrome 61 phase IIb study 61 Guanilib 61 Curaxin CBLC# 61 orally inhaled migraine 61 Onalta 61 5 HT2A inverse 61 OMP #M# 61 immunoconjugate 61 Daptomycin 61 Sorafenib Nexavar 61 orally dosed 61 Laquinimod 61 Sym# 61 Telithromycin 61 Cethrin R 61 Glycopyrrolate 61 oxymorphone ER 61 Ceftaroline 61 Ophena 61 Cleviprex TM clevidipine 61 Intravenous Human 61 Xelox 61 direct thrombin inhibitors 61 Investigational Treatment 61 Initiate Phase III 61 gamma secretase inhibitor 61 BARACLUDE ® 61 liver resection surgeries 61 apomorphine hydrochloride 61 MGd 61 Etravirine 61 zidovudine AZT 61 BRIM2 61 GLP1 agonist 61 GTC recombinant human 61 tezampanel 61 Mycophenolate Mofetil 61 plus prednisone 61 mycophenolate mofetil MMF 61 Files Investigational 61 CD4 monoclonal antibody 61 MetroGel 61 neuraminidase inhibitor 61 omega interferon 61 tanespimycin 61 ChronVac C 61 humanized monoclonal antibody 61 sodium Injection 61 liposome injection 61 PRTX 61 huN# DM1 61 systemic immunosuppressive drugs 61 bevirimat Study 61 rosiglitazone maleate 61 investigational HCV polymerase 61 Electronic Brachytherapy System 61 Sudhir Agrawal D.Phil 61 Emtriva Viread 61 Amgen Neulasta R 61 CTAP# Injection 61 Phase IIb clinical trials 61 telaprevir VX 61 PRN FDA Approves 61 Microplasmin 61 small molecule glucokinase 61 Bayer HealthCare Onyx Pharmaceuticals 61 OAB overactive bladder 61 ThermoDox ® 61 Campath ® 61 hyaluronidase enzyme 61 synthetic retinoid 61 Emtriva emtricitabine 61 lintuzumab SGN 61 oxybutynin ATD TM 61 HMG CoA reductase inhibitors 61 PEG IFN 61 CD# monoclonal antibody 61 treatment naive genotype 61 triciribine phosphate monohydrate 61 SELZENTRY 61 Phase 1b clinical 61 abacavir sulfate lamivudine 61 CCX# B 61 Alfacell proprietary ribonuclease 61 non nucleoside 61 PERLANE 61 clinical trials Archexin 61 IMiDs 61 cyclobenzaprine hydrochloride extended 61 novel histone deacetylase 61 idarubicin 61 metastatic pancreatic 61 CHOP chemotherapy 61 Aeroquin 61 label Lipofen R 61 Blinatumomab 61 telaprevir dosed 61 peripherally restricted 61 Toxoid 61 Glatiramer acetate 61 Dabigatran 61 sulfonylhydrazine class 61 Platinol ® cisplatin 61 Trastuzumab DM1 61 EOquin 61 investigational integrase inhibitor 61 Pivotal Trial 61 cytidine nucleoside analog 61 IgG1 monoclonal antibody 61 inhaled liposomal ciprofloxacin 61 Vaprisol 61 Kinesin Spindle Protein KSP 61 advanced metastatic renal 61 Pivotal Study 61 incyclinide 61 TYKERB 61 MEK inhibitors 61 vorinostat 61 MKC# MT 61 Oral NKTR 61 anti angiogenic agent 61 Vicriviroc 61 lamivudine zidovudine 61 class mGluR5 inhibitor 61 RenaZorb TM 61 occlusion PAO 61 Davanat 61 RTP #i 61 AMEVIVE 61 selective immunoproteasome inhibitor 61 sapropterin dihydrochloride 61 NS#/#A protease 61 phase Ib clinical 61 Aganocide ® 61 Valopicitabine 61 Tindamax 61 Dapagliflozin 61 mild vasodilator 61 Cetrorelix 61 Phase 2a Clinical Trial 61 Initiated Phase 61 Azedra 61 ospemifene 61 sulodexide 61 Nebulized 61 Eniluracil 61 Cloretazine R VNP#M 61 Sanvar R 61 initiated Phase Ib 61 compound ISA# 61 TRANSDUR Sufentanil 61 tenofovir emtricitabine 61 DOXIL 61 Pivotal Clinical Trial 61 relapsed refractory multiple myeloma 61 cell lymphoma CTCL 61 unfractionated heparin UFH 61 Alferon N 61 Capecitabine 61 dimebon latrepirdine 61 vascular disrupting agent 61 Tazobactam 61 drug ISA# 61 EVIZON TM squalamine lactate 61 DIRECT Trial 61 Saladax Biomedical 61 Durezol 60 Vitaxin 60 Lisofylline LSF 60 HuMax CD#b 60 ATL# [001] 60 Imetelstat 60 lenalidomide Revlimid ® 60 CYT# vascular disrupting 60 recombinant PSMA vaccine 60 Allovectin 7 60 Phase 2b clinical trials 60 Fluvastatin 60 ganetespib 60 hormone refractory metastatic prostate 60 compound INCB# 60 RELOVAIR ™ 60 azacytidine 60 transcriptase inhibitor NNRTI 60 Ropinirole 60 budesonide foam 60 Ceflatonin 60 INVANZ 60 fluoropyrimidine 60 Rhinocort 60 investigational oral inhibitor 60 mycophenolic acid 60 dependent kinase inhibitor 60 bone marrow reticulin deposition 60 evaluating T DM1 60 XYNTHA 60 fostamatinib 60 sunitinib malate 60 Tipranavir 60 mitoxantrone plus 60 Recombinant Human 60 Sprycel dasatinib 60 TAXUS Element Paclitaxel Eluting 60 Pyridorin 60 ONCONASE R 60 romidepsin 60 Initiates Clinical Trial 60 compound PMX # 60 Luteinizing Hormone Releasing Hormone 60 protease inhibitor PI 60 nelfinavir Viracept 60 antibody MAb 60 methylnaltrexone 60 ENMD # 60 Ceflatonin ® 60 Mepact 60 PSN# [001] 60 ZALBIN 60 Protexia R 60 STEDESA 60 Famotidine 60 Darusentan 60 Begins Dosing 60 HCV polymerase 60 EVIZON TM 60 oral Janus kinase 60 systemically administered 60 GLP1 INT TM 60 alpha folate receptor 60 tumors GIST 60 #mg/#mg 60 IONSYS TM 60 Fortical R 60 Perforomist ™ Inhalation Solution 60 containing granisetron 60 Immunotherapeutic 60 granulated mesalamine 60 ocular formulation 60 #I TM# 60 Drug Candidate 60 diarrhea predominant irritable 60 Ixabepilone 60 Velcade bortezomib 60 motexafin gadolinium Injection 60 TYZEKA 60 eniluracil 60 huC# DM4 60 non peptidic protease 60 Alkeran 60 Angiotensin Converting Enzyme 60 Phase #b/#a 60 metastatic androgen independent 60 thiazolidinedione TZD 60 BCR ABL inhibitor 60 investigational immunotherapy 60 Viread tenofovir disoproxil fumarate 60 BMS # 60 phase Ib 60 Fluconazole 60 small molecule chemotherapeutic 60 SCH # 60 confirmatory Phase III 60 Dyloject TM 60 tetracycline antibiotic 60 autologous cellular immunotherapy 60 progressive metastatic prostate 60 administered concomitantly 60 highly selective endothelin 60 Plicera 60 Amrubicin 60 Zirgan 60 MT# MEDI 60 acute HAE attacks 60 novel synthetic peptide 60 Pimavanserin 60 markets Gelclair R 60 CCR5 inhibitor 60 ongoing Phase 1b 60 Valtropin 60 ALN TTR# 60 dihydroergotamine 60 Initiates Phase 2b 60 de novo kidney transplant 60 Medoxomil 60 docetaxel chemotherapy 60 dose escalation clinical 60 Testosterone MDTS ® 60 Multaq dronedarone 60 meropenem 60 Phase 2a Trial 60 Lubiprostone 60 Virulizin ® 60 ZYVOX 60 XOMA 3AB 60 torezolid 60 ILUVIEN ® 60 inhalation powder 60 novel emulsion formulation 60 metastatic colorectal carcinoma 60 Sphingomab TM 60 brivanib 60 Augment ™ 60 Budesonide foam crofelemer 60 R roscovitine CDK cyclin 60 TELCYTA TM TLK# 60 GRN# 60 MVA HPV IL2 60 Natazia 60 PresbyLens ® 60 Gilead Viread 60 macrolide antibiotic 60 Achieves Primary Endpoint 60 liposomal amphotericin B 60 Intravail ® 60 Racivir 60 intravenously administered 60 Ofatumumab